Penglong Cao

Statistics

Publications

Citations

108

H-Index

Active since

2018

Affiliations

First Affiliated Hospital of Dalian Medical University(Current)

Dalian Medical University

Penglong Cao is an author at First Affiliated Hospital of Dalian Medical University specializing in oncology, cancer cell signaling, and molecular oncology.

ORCID

Publications per year

2018–2024

Publications

GPX2 suppression of H2O2 stress regulates cervical cancer metastasis and apoptosis via activation of the β-catenin-WNT pathway

Yingxin Wang, Penglong Cao, Mohammed Alshwmi et al. · OncoTargets and Therapy · 2019 · 43 citations · Full text

Medicine, Molecular Biology, Oncology +17

Trametinib potentiates TRAIL‐induced apoptosis via FBW7‐dependent Mcl‐1 degradation in colorectal cancer cells

Lin Lin, Dapeng Ding, Xiaoguang Xiao et al. · Journal of Cellular and Molecular Medicine · 2020 · 26 citations · Full text

Life Sciences, Oncology, Pharmacology +17

BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway

Penglong Cao, Shuai Zhao, Zhigang Sun et al. · Experimental Cell Research · 2018 · 15 citations

Medicine, Cancer Biology, Oncology +14

Novel serum peptide model revealed by MALDI-TOF-MS and its diagnostic value in early bladder cancer

Dapeng Ding, Mingying Chen, Xiaoguang Xiao et al. · The International Journal of Biological Markers · 2020 · 14 citations · Full text

Medicine, Biochemistry, Oncology +17

BRMS1L confers anticancer activity in non-small cell lung cancer by transcriptionally inducing a redox imbalance in the GPX2-ROS pathway

Penglong Cao, Juebin Gu, Mulin Liu et al. · Translational Oncology · 2024 · 10 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 5